Font Size: a A A
Keyword [nab-paclitaxel]
Result: 1 - 16 | Page: 1 of 1
1. Efficacy And Safety Of Nanoparticle Albumin-Bound Paclitaxel For Treating Metastatic Breast Cancer:A Meta-Analysis
2. An Experimental Study Of The Combination Therapy Of S-1 And Nab-paclitaxel On Pancreatic Cancer
3. The Relationship Between The Expression Of SPARC And The Efficacy Of Nab-paclitaxel In The Treatment Of Advanced NSCLC
4. Clinical Observation Of Nab-Paclitaxel Monotherapy In Elderly Advanced Non-Small Cell Lung Cancer
5. Estrogen Receptor Signal Pathway Attenuate The Sensitivity Of Nab-paclitaxel Through Inhibiting The Expression Of Caveolin1 In Breast Cancer
6. A Comparative Study Of Gemcitabine Combined With S-1 Or Nab-paclitaxel In The First-line Treatment Of Advanced Pancreatic Cancer
7. Efficacy And Safety Of Nanoparticle-Albumin-bound Paclitaxel For Metastatic Breast Cancer
8. Based On The Study Of Multifunctional Nanomaterials Co-delivery Salinomycin And Nab-paclitaxel For Targeting Breast Cancer And Metastasis
9. Clinical Study Of Adjuvant Chemotherapy Of Gemcitabine Monotherapy Or Nab-paclitaxel Combined With Gemcitabine After Radical Operation Of Pancreatic Cancer
10. Efficacy And Safety Of Gemcitabine-based And Modified FOLFIRINOX Chemotherapy For Advanced Pancreatic Cancer:A Clinical Comparison Study
11. Comparative Effectiveness Of FOLFIRINOX And Gemcitabine Plus Nab-paclitaxel In Pancreatic Cancer:a Meta-analysis
12. Analysis Of Recurrence Factors After Pancreatic Cancer Surgery And Evaluation Of Adjuvant Chemotherapy With Gemcitabine Plus Nab-paclitaxel
13. A Systematic Review And Meta-analysis Of The Safety And Efficacy Of S-1 Combined With Nab-paclitaxel In The Treatment Of Elderly Patients With Advanced Pancreatic Cancer
14. Analysis Of Related Factors Of Peripheral Neurotoxicity Induced By Nanoparticle Albumin Bound Paclitaxel Injection In Advanced Breast Cancer
15. First-line Treatment With Atezolizumab Plus Nab-paclitaxel For Advanced Triple-negative Breast Cancer: A Cost-utility Analysis
16. Comparison Of The Incidence And Severity Of Peripheral Neuropathy Induced By Solvent-based Paclitaxel And Nab-paclitaxel
  <<First  <Prev  Next>  Last>>  Jump to